Matches in SemOpenAlex for { <https://semopenalex.org/work/W2076504178> ?p ?o ?g. }
Showing items 1 to 89 of
89
with 100 items per page.
- W2076504178 abstract "The discovery of the fusion gene echinodermmicro tubule associated proteinlike 4-anaplastic lymphoma kinase, EML4-ALK, in patients with non-small-cell lung cancer has led to the remarkable development of anaplastic lymphoma kinase inhibitors, such as crizotinib. Consequently, the clinical outcomes of these patients have improved dramatically. Herein, we report the case of a woman with ALK gene translocation-squamous cell lung cancer who experienced a remarkable tumor response to crizotinib after two courses of failed chemotherapy.A 55-year-old Chinese woman was diagnosed with cervical lymph node metastatic squamous carcinoma. Chest computed tomography scan showed the primary tumor in the lower lobe of the right lung. The patient had received two successive courses of first-line chemotherapy without tumor response. Tumor cells were negative for wild-type of epidermal growth factor receptor/K-RAS variants; thus, she was not eligible for tyrosine kinase inhibitor therapy. Unfortunately, increased levels of interleukin-6 and carcinoembryonic antigen, and computed tomography scan results indicated cancer progression. Once crizotinib was approved by the China Food and Drug Administration and the ALK gene translocation was identified in tumor cells by fluorescent in situ hybridization, the patient commenced treatment with crizotinib. Remarkably, the tumor response to crizotinib was classified as partial response after only 26 days of treatment commencement. The partial response status has been maintained to date (23 weeks).Considering this remarkable response to crizotinib, we can safely conclude that patients with squamous cell lung cancer should have the option of undergoing ALK testing to determine if there is indication for crizotinib treatment even after they have failed chemotherapy." @default.
- W2076504178 created "2016-06-24" @default.
- W2076504178 creator A5003953361 @default.
- W2076504178 creator A5007825172 @default.
- W2076504178 creator A5037018453 @default.
- W2076504178 creator A5040601958 @default.
- W2076504178 creator A5058279520 @default.
- W2076504178 date "2014-05-15" @default.
- W2076504178 modified "2023-10-07" @default.
- W2076504178 title "Extraordinary response to crizotinib in a woman with squamous cell lung cancer after two courses of failed chemotherapy" @default.
- W2076504178 cites W2031494655 @default.
- W2076504178 cites W2040636001 @default.
- W2076504178 cites W2048225862 @default.
- W2076504178 cites W2113149312 @default.
- W2076504178 cites W2139110945 @default.
- W2076504178 cites W2145099193 @default.
- W2076504178 cites W2145472255 @default.
- W2076504178 cites W2153345506 @default.
- W2076504178 cites W2161650275 @default.
- W2076504178 doi "https://doi.org/10.1186/1471-2466-14-83" @default.
- W2076504178 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4027997" @default.
- W2076504178 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24885608" @default.
- W2076504178 hasPublicationYear "2014" @default.
- W2076504178 type Work @default.
- W2076504178 sameAs 2076504178 @default.
- W2076504178 citedByCount "17" @default.
- W2076504178 countsByYear W20765041782015 @default.
- W2076504178 countsByYear W20765041782016 @default.
- W2076504178 countsByYear W20765041782017 @default.
- W2076504178 countsByYear W20765041782018 @default.
- W2076504178 countsByYear W20765041782019 @default.
- W2076504178 countsByYear W20765041782021 @default.
- W2076504178 countsByYear W20765041782022 @default.
- W2076504178 countsByYear W20765041782023 @default.
- W2076504178 crossrefType "journal-article" @default.
- W2076504178 hasAuthorship W2076504178A5003953361 @default.
- W2076504178 hasAuthorship W2076504178A5007825172 @default.
- W2076504178 hasAuthorship W2076504178A5037018453 @default.
- W2076504178 hasAuthorship W2076504178A5040601958 @default.
- W2076504178 hasAuthorship W2076504178A5058279520 @default.
- W2076504178 hasBestOaLocation W20765041781 @default.
- W2076504178 hasConcept C117643217 @default.
- W2076504178 hasConcept C121608353 @default.
- W2076504178 hasConcept C126322002 @default.
- W2076504178 hasConcept C142724271 @default.
- W2076504178 hasConcept C143998085 @default.
- W2076504178 hasConcept C2776232967 @default.
- W2076504178 hasConcept C2776256026 @default.
- W2076504178 hasConcept C2776694085 @default.
- W2076504178 hasConcept C2777872185 @default.
- W2076504178 hasConcept C2779338263 @default.
- W2076504178 hasConcept C2779422266 @default.
- W2076504178 hasConcept C502942594 @default.
- W2076504178 hasConcept C71924100 @default.
- W2076504178 hasConceptScore W2076504178C117643217 @default.
- W2076504178 hasConceptScore W2076504178C121608353 @default.
- W2076504178 hasConceptScore W2076504178C126322002 @default.
- W2076504178 hasConceptScore W2076504178C142724271 @default.
- W2076504178 hasConceptScore W2076504178C143998085 @default.
- W2076504178 hasConceptScore W2076504178C2776232967 @default.
- W2076504178 hasConceptScore W2076504178C2776256026 @default.
- W2076504178 hasConceptScore W2076504178C2776694085 @default.
- W2076504178 hasConceptScore W2076504178C2777872185 @default.
- W2076504178 hasConceptScore W2076504178C2779338263 @default.
- W2076504178 hasConceptScore W2076504178C2779422266 @default.
- W2076504178 hasConceptScore W2076504178C502942594 @default.
- W2076504178 hasConceptScore W2076504178C71924100 @default.
- W2076504178 hasIssue "1" @default.
- W2076504178 hasLocation W20765041781 @default.
- W2076504178 hasLocation W20765041782 @default.
- W2076504178 hasLocation W20765041783 @default.
- W2076504178 hasLocation W20765041784 @default.
- W2076504178 hasOpenAccess W2076504178 @default.
- W2076504178 hasPrimaryLocation W20765041781 @default.
- W2076504178 hasRelatedWork W2072208304 @default.
- W2076504178 hasRelatedWork W2278530099 @default.
- W2076504178 hasRelatedWork W2343885620 @default.
- W2076504178 hasRelatedWork W2493967039 @default.
- W2076504178 hasRelatedWork W2516942920 @default.
- W2076504178 hasRelatedWork W2797353951 @default.
- W2076504178 hasRelatedWork W2920965313 @default.
- W2076504178 hasRelatedWork W3019507878 @default.
- W2076504178 hasRelatedWork W3112266211 @default.
- W2076504178 hasRelatedWork W3197633853 @default.
- W2076504178 hasVolume "14" @default.
- W2076504178 isParatext "false" @default.
- W2076504178 isRetracted "false" @default.
- W2076504178 magId "2076504178" @default.
- W2076504178 workType "article" @default.